. siRNA sequences targeting clathrin isoforms and -tubulin have reproducible effects on multiple HeLa cell clones. (A) HeLa-GFP--tubulin cells were treated with siRNA (20 nM total) targeting CHC17 (siCHC17), CLCs LCa and LCb (siCLC), CHC22 (siCHC22), both CHC17 and CLC (siCHC17 + siCLC), -tubulin (si--tubulin), or nontargeting siRNA. Cell lysates prepared 48 h after transfection were analyzed for target protein depletion compared with -actin (loading control). Using densitometry, protein levels for all clathrin isoforms and -tubulin were established as a ratio over -actin and are shown as a percentage of the corresponding protein ratio seen with nonsilencing siRNA conditions (dotted lines). Data represent the mean ± SEM of two separate experiments. (B) HeLa-GFP--tubulin cells were treated with siRNA-targeting clathrin isoforms, -tubulin, or nonsilencing siRNA, harvested 72 h after siRNA transfection, and then analyzed for target protein expression, as in A. Data represent the mean ± SEM of three separate experiments. (C) HeLacentrin-2-GFP cells were treated with siRNA-targeting clathrin isoforms or nonsilencing siRNA, harvested 72 h after siRNA transfection, and then analyzed for target protein expression, as in A. Data represent the mean ± SEM of two separate experiments. Figure S4 . Acute inactivation of clathrin in S phase does not interfere with cell cycle progression. Parental HeLa and clone 3.3 HeLa cells were enriched to S phase by T/T block and treated at T 0 after T/T with BG-GLA-BG or DMSO (mock), as in Fig. 7 A. Cells were harvested at 0, 2, 4, 6, 8, 10, and 24 h after release from T/T block, labeled with propidium iodide, and then analyzed by flow cytometry. The proportion of cells in each phase of the cell cycle, based on propidium iodide signal, is shown for DMSO-treated parental HeLa, BG-GLA-BG-treated parental HeLa, DMSO-treated clone 3.3 HeLa, and BG-GLA-BG-treated clone 3.3 HeLa. Data represent the mean ± SEM of two separate experiments.
